DK0786991T3 - Polyaminforbindelsre til behandling af proliferative karsygdomme - Google Patents

Polyaminforbindelsre til behandling af proliferative karsygdomme

Info

Publication number
DK0786991T3
DK0786991T3 DK95934421T DK95934421T DK0786991T3 DK 0786991 T3 DK0786991 T3 DK 0786991T3 DK 95934421 T DK95934421 T DK 95934421T DK 95934421 T DK95934421 T DK 95934421T DK 0786991 T3 DK0786991 T3 DK 0786991T3
Authority
DK
Denmark
Prior art keywords
treatment
vascular diseases
polyamine compounds
proliferative vascular
proliferative
Prior art date
Application number
DK95934421T
Other languages
Danish (da)
English (en)
Inventor
Donald Hupe
Joan Alexis Keiser
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Application granted granted Critical
Publication of DK0786991T3 publication Critical patent/DK0786991T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK95934421T 1994-10-25 1995-09-14 Polyaminforbindelsre til behandling af proliferative karsygdomme DK0786991T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/329,588 US5516807A (en) 1994-10-25 1994-10-25 Method for treating vascular proliferative disorders following balloon angioplasty
PCT/US1995/011680 WO1996012480A1 (en) 1994-10-25 1995-09-14 Polyamine compounds for treating vascular proliferative disorders

Publications (1)

Publication Number Publication Date
DK0786991T3 true DK0786991T3 (da) 2001-03-19

Family

ID=23286110

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95934421T DK0786991T3 (da) 1994-10-25 1995-09-14 Polyaminforbindelsre til behandling af proliferative karsygdomme

Country Status (12)

Country Link
US (1) US5516807A (de)
EP (1) EP0786991B1 (de)
JP (1) JPH10507752A (de)
AT (1) ATE198706T1 (de)
CA (1) CA2198914A1 (de)
DE (1) DE69519937T2 (de)
DK (1) DK0786991T3 (de)
ES (1) ES2155531T3 (de)
GR (1) GR3035725T3 (de)
MX (1) MX9701838A (de)
PT (1) PT786991E (de)
WO (1) WO1996012480A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5811447A (en) 1993-01-28 1998-09-22 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6515009B1 (en) 1991-09-27 2003-02-04 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6306421B1 (en) 1992-09-25 2001-10-23 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5770609A (en) 1993-01-28 1998-06-23 Neorx Corporation Prevention and treatment of cardiovascular pathologies
US6251920B1 (en) 1993-05-13 2001-06-26 Neorx Corporation Prevention and treatment of cardiovascular pathologies
US5981568A (en) 1993-01-28 1999-11-09 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6491938B2 (en) 1993-05-13 2002-12-10 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6663881B2 (en) 1993-01-28 2003-12-16 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
AU6277396A (en) * 1995-06-07 1996-12-30 Neorx Corporation Prevention and treatment of cardiovascular pathologies with tamoxifen analogues
US7611533B2 (en) * 1995-06-07 2009-11-03 Cook Incorporated Coated implantable medical device
JP3470901B2 (ja) * 1996-09-13 2003-11-25 ユニヴァーシティ オブ フロリダ リサーチ ファウンデーション，インコーポレイテッド Ｅｌｆ５Ａ生合成の抑制方法
US6083991A (en) * 1997-06-04 2000-07-04 University Of Florida Research Foundation, Inc. Anti-arrhythmic composition and methods of treatment
US7087648B1 (en) * 1997-10-27 2006-08-08 The Regents Of The University Of California Methods for modulating macrophage proliferation using polyamine analogs
US8198334B2 (en) * 1997-10-27 2012-06-12 Pathologica Llc Methods for modulating macrophage proliferation in ocular disease using polyamine analogs
EP1698629A3 (de) 1999-04-30 2006-11-29 Cellgate, Inc. Polyamine und ihre therapeutische Verwendung
US6649587B1 (en) 1999-04-30 2003-11-18 Slil Biomedical Corporation Polyamine analog conjugates and quinone conjugates as therapies for cancers and prostate diseases
US6482943B1 (en) * 1999-04-30 2002-11-19 Slil Biomedical Corporation Quinones as disease therapies
CA2368801A1 (en) * 1999-04-30 2000-11-09 Slil Biomedical Corporation Conjugates as therapies for cancer and prostate diseases
EP1337504A4 (de) * 2000-11-08 2005-10-05 Cellgate Inc Neue polyaminanalogon-aminosäure-konjugate zur verwendung als krebsmittel
US6982351B2 (en) * 2001-12-07 2006-01-03 Cellgate, Inc. Cycloalkyl substituted polyamines for cancer therapy and methods of synthesis therefor
JP2004189714A (ja) * 2002-12-09 2004-07-08 Rasanen Tiina-Liisa すい臓炎の治療と予防ならびに肝臓再生機能の誘導のための薬剤
JP2008515800A (ja) * 2004-10-04 2008-05-15 セルゲイト， インコーポレイテッド 眼科疾患の処置剤としてのポリアミン類似化合物
US20070232677A1 (en) * 2006-03-14 2007-10-04 Marton Laurence J Treatment and prevention of vascular hyperplasia using polyamine and polyamine analog compounds
US8709419B2 (en) * 2010-08-17 2014-04-29 Hoffmann-La Roche, Inc. Combination therapy
US9295669B2 (en) 2010-12-14 2016-03-29 Hoffman La-Roche Inc. Combination therapy for proliferative disorders

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS606348B2 (ja) * 1976-03-31 1985-02-18 三菱化学株式会社 新規ポリアミン類
JPS58135809A (ja) * 1982-02-05 1983-08-12 Fujisawa Pharmaceut Co Ltd 抗炎症・抗リウマチ剤
US4507321A (en) * 1982-02-17 1985-03-26 The Research Foundation Of State University Of New York Epithelial cell growth regulating composition containing polyamines and a method of using same
JPS606348A (ja) * 1983-06-09 1985-01-14 ケルベル・アクチエンゲゼルシヤフト 回転研削工具の支承装置
NZ212053A (en) * 1984-05-17 1988-02-29 Merrell Dow Pharma Polyamine containing pharmaceutical compositions for treating neoplasms
US5091576A (en) * 1986-12-02 1992-02-25 University Of Florida Anti-neoplastic, anti-viral or anti-retroviral spermine derivatives
CA1338764C (en) * 1987-02-03 1996-12-03 David M. Stemerick Polyamine derivatives
ZA903804B (en) * 1989-05-23 1991-03-27 Merrell Dow Pharma A method of potentiating cell-mediated immunity utilizing polyamine derivatives

Also Published As

Publication number Publication date
PT786991E (pt) 2001-04-30
GR3035725T3 (en) 2001-07-31
ES2155531T3 (es) 2001-05-16
EP0786991A1 (de) 1997-08-06
ATE198706T1 (de) 2001-02-15
CA2198914A1 (en) 1996-05-02
DE69519937D1 (de) 2001-02-22
WO1996012480A1 (en) 1996-05-02
JPH10507752A (ja) 1998-07-28
DE69519937T2 (de) 2001-06-07
MX9701838A (es) 1997-06-28
EP0786991B1 (de) 2001-01-17
US5516807A (en) 1996-05-14

Similar Documents

Publication Publication Date Title
DK0786991T3 (da) Polyaminforbindelsre til behandling af proliferative karsygdomme
DK1039912T3 (da) Angiostatiske midler og præparater til behandling af GLC1A-glaukom
DE69726724D1 (de) Tetrahydropteridine und pyridylpiperazine zur behandlung von neurologischen störungen
PL342078A1 (en) Inhibition of raf kinase using symmetrical and dissymmetrical substituted dimethylureas
PT971713E (pt) Utilizacao de inibidores da colinesterase para tratamento de desordens da atencao
DE69826695D1 (de) Arylharnstoffderivate zur behandlung von inflammatorischen oder immunomodulatorischen erkrankungen
DK0805807T3 (da) 2-(2-Amino-3-methoxyphenyl)-4-oxo-4H-(1)-benzopyran til behandling af proliferative sygdomme
DK1539166T3 (da) Farmaceutiske sammensætninger indeholdende dextromethorphan og quinidin til behandling af neurologiske sygdomme
DE60037394D1 (de) VERWENDUNG VON p53 INHIBITOREN ZUR BEHANDLUNG VON NEBENERSCHEINUNGEN BEI DER KREBSTHERAPIE
PT1042305E (pt) Inibicao de quinase p38 utilizando difenilureias simetricas e assimetricas
IL144643A0 (en) Jak-3 inhibitors for treating allergic disorders
DE69430309D1 (de) Dilatationskatheter und verfahren zur behandlung damit
HK1155944A1 (en) W-carboxy aryl substituted diphenyl ureas as p38 kinase inhibitors
ATE282425T1 (de) Verfahren zur behandlung von endothelialen verletzungen
ATE208384T1 (de) Verwendung von ascorbyl-gamma-linolenat und von ascorbyl-dihomo-gamma-linolenat zur behandlung von asthma, krebs, kardiovaskulären und inflammatorischen erkrankungen
DE69841041D1 (de) Stent beschichtet mit dna
DE69432626D1 (de) Melatonin-Derivate zur Verwendung in der Behandlung von Desynchronisierungs-Erkankungen
DE69626816D1 (de) Verwendung von selegilin zur behandlung von gehörverlust bei säugetieren
MX9304626A (es) Derivados heterociclicos utiles en el tratamiento de enfermedades cardiovasculares.
PL334498A1 (en) Application of pramiprexole in treating the restless legs syndrome
ES2190581T3 (es) 2-aminotetralina opticamente activa, procedimiento para su preparacion y composiciones farmaceuticas que la contienen, activa en la prevencion y tratamiento de shock septico.
DK1140119T3 (da) Anvendelse af heparin med lav molekylvægt til forebyggelse og/eller behandling af motorneuronale sygdomme
DK0869813T3 (da) Anvendelse af beta-interferoner til behandling af restenose
DK0984787T3 (da) Anvendelse af lavmolekylære hepariner til forebyggelse og behandling af hjerneødemer
ATE269714T1 (de) Tcf-ii für vorbeugung und/oder behandlung von strahlungsinduzierter störungen